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    Pharmacokinetic drug resistance often leads to failure of an anticancer therapy. One 
of the mechanisms is increased efflux of drugs from tumour cells, whereas some 
studies suggest that increased drug conversion to an inactive metabolite might be 
another contributing mechanism. The aim of this work was to define the possible role 
of CYP3A4 and CYP2C8 enzymes in the phenomenon of pharmacokinetic resistance 
and to investigate the possibility of its modulation by new targeted drugs. In the first 
part, we used the MTT proliferation method together with HepG2 cells stably 
transduced with particular human enzymes and demonstrated significant involvement 
of CYP3A4 in docetaxel resistance. In the following part, we examined the inhibitory 
effects of four selected tyrosine kinase inhibitors on the CYP3A4 activity in intact cells 
using a commercial kit. Cobimetinib and dabrafenib showed significant inhibitory 
activity, while osimertinib and brivanib did not. In the final part, we demonstrated the 
ability of the first two mentioned drugs to modulate resistance to docetaxel mediated 
by CYP3A4 using the MTT assay. Our results might be used as a valuable basis for 
understanding the role of biotransformation enzymes in the drug resistance 
phenomenon. The results of the combination experiments point to the synergistic effect 
of the studied compounds, which could possibly be used in antitumour therapy. 
 
